ACS Medicinal Chemistry Letters · 2021 · 53 citations · 37 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignPharmacophore ModelingStructure-activity RelationshipsAntiviral AgentsAntiviral PharmacologyEnzyme InhibitionLigand BindingLigand-based DesignStructure-activity Relationship AnalysisActive Site AnalysisAntiviral Structure-activity RelationshipsMedicinal Chemistry ApplicationsPharmacophore Model ConstructionPharmacophore Model OptimizationPharmacophore Model RefinementSars-cov-2 InfectionStructure-activity Relationship Modeling
For the first time, derivatives of 3,7-diazabicyclo[3.3.1]nonane (bispidine) were proposed as potential inhibitors of the SARS-CoV-2 main viral protease (3-chymotrypsin-like, 3CLpro). Based on the created pharmacophore model of the active site of the protease, a group of compounds were modeled and tested for activity against 3CLpro. The 3CLpro activity was measured using the fluorogenic substrate Dabcyl-VNSTLQSGLRK(FAM)MA; the efficiency of the proposed approach was confirmed by comparison with literature data for ebselen and disulfiram. The results of the experiments performed with bispidine compounds showed that 14 compounds exhibited activity in the concentration range 1-10 μM, and 3 samples exhibited submicromolar activity. The structure-activity relationship studies showed that the molecules containing a carbonyl group in the ninth position of the bicycle exhibited the maximum activity. Based on the experimental and theoretical results obtained, further directions for the development of this topic were proposed.
37
Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease
Wenhao Dai, Bing Zhang, Xia-Ming Jiang et al. · Science · 2020 · 1.6K citations · Full text
Robert L. Hoffman, Robert S. Kania, Mary A. Brothers et al. · Journal of Medicinal Chemistry · 2020 · 533 citations · Full text